The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Post-protocol therapies in first-line immunotherapy trials in non–small cell lung cancer (NSCLC).
 
Aakash Desai
No Relationships to Disclose
 
Aaron Scott Mansfield
Honoraria - Roche
Consulting or Advisory Role - Abbvie (Inst); AstraZeneca (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Janssen (Inst)
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Abbvie; Roche
Other Relationship - Mesothelioma Applied Research Foundation
 
Anuhya Kommalapati
No Relationships to Disclose
 
Konstantinos Leventakos
Consulting or Advisory Role - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Janssen Oncology (Inst); Jazz Pharmaceuticals (Inst); Mirati Therapeutics (Inst); MJH Life Sciences (Inst); OncLive (Inst); Regeneron (Inst); Takeda (Inst); Targeted Oncology (Inst)
Research Funding - AstraZeneca (Inst); Mirati Therapeutics (Inst)
 
Alex A. Adjei
Consulting or Advisory Role - EMD Serono; Janssen; Mirati Therapeutics; Swiss Rockets; Zai Lab
Research Funding - Bayer Schering Pharma (Inst); I-Mab (Inst); Jacobio (Inst); Kura Oncology (Inst); Merck KGaA (Inst); Tesaro (Inst); Zai Lab (Inst)
(OPTIONAL) Uncompensated Relationships - Merck KGaA; Swiss Rockets; Zai Lab
 
Howard Jack West
Honoraria - AstraZeneca; Genentech/Roche; Merck; Mirati Therapeutics; Regeneron; Takeda
Consulting or Advisory Role - AstraZeneca; Genentech/Roche; Merck; Mirati Therapeutics; Regeneron; Regeneron; Takeda
Speakers' Bureau - AstraZeneca; Merck; Takeda